Duet Scanning System
Rare cells detection (RCD)
Code of Business Conduct
Breast & Tissue
Duet - Uncultured Amniocytes
Duet - Hematology
Duet - Bladder Cancer
Duet - Karyotyping
Duet - Breast Cancer
Duet - Metaphases
Duet -TIssue FISH
Duet - Circulating Tumor Cells
BioView and Abbott have entered into a joint development agreement
Abbott plans to develop FISH probes for Research Use Only (RUO) and in-vitro diagnostic (IVD) purposes worldwide and BioView will develop software and software applications for the automated imaging of the FISH probes on the BioView Duet family of systems.
FDA Clears BioView Duet™ System for Automated ALK FISH Scanning of Lung Cancer Tissue Specimens
The United States Food and Drug Administration (FDA) cleared for marketing in the United States its automated scanning microscope and image analysis system, the Duet™ system, to qualitatively detect rearrangements involving the ALK gene via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens, probed with the Abbott Vysis® ALK Break Apart FISH Probe Kit.
BioView and Kindstar signed an agreement to validate and implement BioView’s Lung Cancer FISH test
Under the agreement, Kindstar will have an exclusive license to validate and implement BioView’s Lung Cancer FISH test for an aid in early detection of Lung Cancer in its clinical laboratories.
BioView Enters into Distribution Agreement with Abbott
Under the agreement, Abbott will distribute BioView’s Duet fluorescence in situ hybridization (FISH) workstations,for clinical applications, worldwide. Abbott will have exclusive distribution rights of BioView’s products in all territories other than the United States and Canada.
BioView and Kindstar Agreed Collaboration on Lung Cancer Test Kit
BioView Ltd. and Kindstar Global agreed to launch a Pilot Study of the BioView Lung Cancer Detection Kit in China.
BioView Releases a New Karyotyping Application
BioView’s wide range of automated Karyotyping and FISH platforms ensure optimal solutions for various sample volumes and automation level requirements.
Abbott to Adopt BioView`s Cell Imaging Software for its Automated Vysis ALK FISH Probe Test
Abbott and BioView, Ltd. have entered into an agreement in which BioView will develop automated digital imaging software for use with Abbott`s molecular diagnostic test to detect rearrangements of the ALK gene in patients with advanced non-small cell lung cancer NSCLC).
BioView and ScreenCell Announce Worldwide Commercial Collaboration Agreement for Circulating Tumor Cell (CTC) Technology
BioView Releases a new Web-Based Review and Analysis Software